RESUMEN
BACKGROUND: Beige adipocytes comprise a unique thermogenic cell type in the white adipose tissue (WAT) of rodents and humans, and play a critical role in energy homeostasis. In this scenario, recruitment of beige cells has been an important focus of interest for the development of novel therapeutic strategies to treat obesity. PPARγ activation by full agonists (thiazolidinediones, TZDs) drives the appearance of beige cells, a process so-called browning of WAT. However, this does not translate into increased energy expenditure, and TZDs are associated with weight gain. Partial PPARγ agonists, on the other hand, do not induce weight gain, but have not been shown to drive WAT browning. The present study was designed to investigate the effects of GQ-16 on BAT and on browning of WAT in obese mice. METHODS: Male Swiss mice with obesity and hyperglycemia induced by high fat diet were treated with vehicle, rosiglitazone (4 mg/kg/d) or the TZD-derived partial PPARγ agonist GQ-16 (40 mg/kg/d) for 14 days. Fasting blood glucose, aspartate aminotransferase, alanine aminotransferase and lipid profile were measured. WAT and brown adipose tissue (BAT) depots were excised for determination of adiposity, relative expression of Ucp-1, Cidea, Prdm16, Cd40 and Tmem26 by RT-qPCR, histological analysis, and UCP-1 protein expression analysis by immunohistochemistry. Liver samples were also removed for histological analysis and determination of hepatic triglyceride content. RESULTS: GQ-16 treatment reduced high fat diet-induced weight gain in mice despite increasing energy intake. This was accompanied by reduced epididymal fat mass, reduced liver triglyceride content, morphological signs of increased BAT activity, increased expression of thermogenesis-related genes in interscapular BAT and epididymal WAT, and increased UCP-1 protein expression in interscapular BAT and in epididymal and inguinal WAT. CONCLUSION: This study suggests for the first time that a partial PPARγ agonist may increase BAT activity and induce the expression of thermogenesis-related genes in visceral WAT. GENERAL SIGNIFICANCE: These findings suggest that PPARγ activity might be modulated by partial agonists to induce WAT browning and treat obesity.
Asunto(s)
Tejido Adiposo Pardo/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Hiperglucemia/complicaciones , Grasa Intraabdominal/efectos de los fármacos , Obesidad/fisiopatología , Termogénesis/genética , Tiazolidinedionas/farmacología , Tejido Adiposo Pardo/metabolismo , Tejido Adiposo Pardo/patología , Adiposidad/efectos de los fármacos , Adiposidad/genética , Animales , Glucemia/metabolismo , Peso Corporal/efectos de los fármacos , Grasa Intraabdominal/metabolismo , Grasa Intraabdominal/patología , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Ratones , Obesidad/complicaciones , Obesidad/genética , Obesidad/patología , PPAR gamma/agonistas , Termogénesis/efectos de los fármacos , Tiazolidinedionas/química , Triglicéridos/metabolismo , Proteína Desacopladora 1/genéticaRESUMEN
Rhinolith is a calcified mass found within the nasal cavity. This article is a case report of a 51-year-old woman with an unusual radiopaque lesion located in the nasal maxillary antrum cavity. It was asymptomatic and found accidentally on a routine panoramic radiograph. The rhinolith is presented along with the description of its clinical, radiographic (conventional and CT images), and histopathologic aspects. The objective of this report is to describe and discuss the differential diagnosis of the rhinolith with other oral injuries or conditions and to show how important it is for dental practitioners to be aware of their existence.
